PCSPARR Stock Latest News
Private CompaniesSparrow Pharmaceuticals Emphasizes Patient-Centered Diabetes Research2d agoSPARR
Private CompaniesSparrow Pharmaceuticals Eyes European Partnerships in Cardiometabolic Care1w agoSPARR
Private CompaniesSparrow Expands Phase 2b Trial of Clofutriben in Type 2 Diabetes1w agoSPARR
Private CompaniesLeadership Focus Underscores Sparrow Pharmaceuticals’ Regulatory Execution Strategy1M agoSPARR
Private CompaniesSparrow Pharmaceuticals Highlights Cardiometabolic Focus at Evercore Biotech Showcase1M agoSPARR
Private CompaniesResearch Focus On Cardiometabolic Disease Highlights Sparrow Pharmaceuticals Strategy1M agoSPARRPrivate CompaniesSparrow Pharmaceuticals Highlights Cardiometabolic Focus at Major Diabetes Conference1M agoSPARR
Private CompaniesSparrow Pharmaceuticals Emphasizes Cortisol Biology in Metabolic Disease Research1M agoSPARR
Private CompaniesSparrow Pharmaceuticals Emphasizes Cortisol Biology in Cardiometabolic Strategy2M agoSPARR
Private CompaniesSparrow Pharmaceuticals Highlights Cortisol-Focused Approach in Cardiometabolic R&D2M agoSPARR
Private CompaniesSparrow Pharmaceuticals CEO Highlights Cortisol’s Role in Challenging Type 2 Diabetes2M agoSPARR
Private CompaniesLeadership Focus Underscores Sparrow Pharmaceuticals’ R&D Culture2M agoSPARR
Private CompaniesSparrow Pharmaceuticals Positions Cardiometabolic Research Beyond GLP-1 Therapies2M agoSPARRPrivate CompaniesSparrow Pharmaceuticals Highlights R&D Focus on Cortisol in Cardiometabolic Disease3M agoSPARR
Private CompaniesSparrow Pharmaceuticals Highlights Cortisol-Focused Strategy in Cardiometabolic R&D3M agoSPARR
Private CompaniesSparrow Pharmaceuticals Emphasizes Integrated Approach to Cardiometabolic Disease4M agoSPARR


